DeepMed Research

British Columbia Cancer Agency

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Active, not recruiting

Conditions: Prostate Cancer
Prostatic Neoplasms

First Posted Date: 2016-09-14

Last Posted Date: 2024-11-07

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 2244

Registration Number: NCT02899312

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada

FDGal PET/CT to Detect Hepatocellular Carcinoma

Withdrawn

Conditions: Liver Cirrhosis
Hepatocellular Carcinoma
Chronic Liver Disease

First Posted Date: 2016-09-14

Last Posted Date: 2023-02-21

Lead Sponsor: British Columbia Cancer Agency

Registration Number: NCT02899325

Locations: 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

Recruiting

Conditions: Cancer
Pancreatic Cancer

Interventions: Procedure: Tumour Biopsy
Other: Serial Collection of Plasma and Serum Samples

First Posted Date: 2016-08-17

Last Posted Date: 2024-05-28

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 190

Registration Number: NCT02869802

Locations: 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada

and more 1 locations

Dynamic Contrast Enhanced HCC SABR Liver Study

Not Applicable

Conditions: Carcinoma, Hepatocellular

Interventions: Procedure: Perfusion Imaging

First Posted Date: 2016-07-28

Last Posted Date: 2016-07-28

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 20

Registration Number: NCT02847767

Locations: 🇨🇦
BC Cancer Agency Fraser Valley Centre, Surrey, British Columbia, Canada
🇨🇦
BC Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada

Cancer DNA Screening Pilot Study (CANDACE)

Not Applicable

Completed

Conditions: Circulating Tumor Cells

Interventions: Genetic: Circulating tumor DNA assay

First Posted Date: 2016-06-22

Last Posted Date: 2020-08-24

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 1514

Registration Number: NCT02808884

Locations: 🇨🇦
BC Cancer Agency- Vancouver Centre, Vancouver, British Columbia, Canada

CEST- Glucose Enhanced MRI for Metastatic Brain Tumours

Phase 2

Terminated

Conditions: Brain Neoplasms, Malignant
Metastasis

Interventions: Procedure: Magnetic resonance imaging
Drug: Gadovist (Gadobutrol)
Drug: 50% dextrose solution

First Posted Date: 2016-06-13

Last Posted Date: 2019-01-28

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 3

Registration Number: NCT02796729

Locations: 🇨🇦
BC Cancer Agency- Vancouver Centre, Vancouver, British Columbia, Canada

Comparison of HDR Vs. LDR Brachytherapy As Monotherapy for Intermediate Risk Prostate Cancer

Phase 3

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: Low dose rate prostate brachytherapy
Radiation: High Dose Rate prostate brachytherapy

First Posted Date: 2016-02-25

Last Posted Date: 2025-03-13

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 60

Registration Number: NCT02692105

Locations: 🇨🇦
British Columbia Cancer Agency Center for the Southern Interior, Kelowna, British Columbia, Canada

A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: Standard Reminder Postcard
Other: Family Physician Reminder Letter

First Posted Date: 2016-01-21

Last Posted Date: 2021-09-30

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 5498

Registration Number: NCT02660788

Locations: 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada

Phase II Study of Perindopril and Regorafenib in mCRC

Phase 2

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: Regorafenib
Drug: Perindopril

First Posted Date: 2016-01-11

Last Posted Date: 2019-09-12

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 12

Registration Number: NCT02651415

Locations: 🇨🇦
BC Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada

(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer

Conditions: Breast Cancer

First Posted Date: 2015-12-11

Last Posted Date: 2016-07-20

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 80

Registration Number: NCT02627703

Locations: 🇨🇦
BC Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy